Replies to post #12443 on ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

Attacking one individual on a 10K is an interesting strategy to employ.

JOSEPH ZAMPETTI and his 7-8 "designees" who actively assisted him are being singled out because of the unarguably high investor relations-related consulting services that were disclosed in the Q's. That is a fact. Perhaps you didn't notice that part of the Q's.

But it is something that most, if not all, other investors want to know about so I'm happy to share this info w/you.

The fact that these services dovetailed so nicely with the orchestrated 16-day P&D promotional campaign from this past summer makes it an extra bitter pill for loyal shareholders to swallow, watching in horror as their investment nosedived from 1.00+ down to .08, and now sitting at .14. These are the true investors who have "skin in the game". I can't imagine any true shareholders who were truly long and truly locked their shares away in a vault w/o selling thru this freefall NOT being upset at those who orchestrated this P&D promotional campaign.

But that is spilt milk at this point of the calendar. The critical takeaway is that the 1,750,000 free shares that remain which were given to JOSEPH ZAMPETTI and his 7-8 designees become unlocked between 12/6/13 and early 2014, with the first tranche of 750,000 shares being added to the float on 12/6/13. So this is something that all investors should be aware of and put on their calendars to be mindful of potential volatility.

It is always wise to be vigilant when paid promoters themselves have truckloads of shares on the cusp of being tradeable as they have a clear conflict of interest and have a direct vested interest in seeing the sp rise as high as possible leading into these dates when their shares unlock and become unrestricted.

Bob Schneirderman has laid the groundwork for a tremendous 2014.

RapiMeds launching in 2014 will truly be a seminal moment for SCRC, no doubt, and I for one cannot wait for that day to arrive. However, this groundwork has come at a heavy price for the true loyal shareholders, and to dismiss what many who are still around have experienced just wouldn't be right or decent.

You refer to "interesting strategies to employ" in your first quote above. What the Q's allow me to look back on are the "interesting strategies" that SCRC employed in laying this groundwork for 2014. Certainly hiring a stock promoter to engage in a promotional campaign that left most, if not all, loyal shareholders in its bloody wake as the sp crashed precipitously from 1.00+ down to .08 was a very very interesting strategy to say the least. And what made this strategy doubly interesting was the fact that loyal shareholders were dealt a double-whammy from this strategy by virtue of SCRC "paying" for this promotion not w/cash -- but w/dilution, which will adversely impact these loyal shareholders even further once the lockup expires and the totality of the 2,000,000+ shares become unrestricted in 2014.

This is a risk. Not an operational-risk, mind you, as something of this nature won't impact SCRC's ability to launch RapiMeds; but rather, it is simply a discussion of stock price risk. Loyal shareholders simply cannot ignore the realities of how continuous dilutive actions adversely impact the sp, both in the short term and in the long term.

GLTU and GLTA...